{
  "success": true,
  "pagesUsed": [
    3,
    9,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    23,
    34,
    57
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 0.9333333333333333,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Screening Window",
        "type": {
          "id": "824383d9-8595-439e-8fdb-ca587afebce0",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "a8d44ba6-f69b-4049-9048-c5823014aac7",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "c70569dc-f715-4f23-9dfc-1e40222efb79",
        "instanceType": "Timing",
        "windowLower": "-P28D",
        "windowUpper": "-P1D"
      },
      {
        "id": "timing_2",
        "name": "Washout Period",
        "type": {
          "id": "5557842a-af3d-4147-be85-6429c678717e",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P0D",
        "valueLabel": "Washout Period",
        "relativeToFrom": {
          "id": "f1aa11fc-e131-49ce-9651-215a9baa7144",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "cffd7630-4c2a-480c-99e2-1a95852e43f7",
        "instanceType": "Timing",
        "windowLower": "P3D",
        "windowUpper": "P14D"
      },
      {
        "id": "timing_3",
        "name": "Follow-up Visit Window",
        "type": {
          "id": "bbc28642-f33a-47fb-b964-b436d6b08d6f",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "1e7f0618-8a5b-45bb-ba07-914d422694f0",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "bc10b241-6cd2-4011-9e98-f273983f1021",
        "instanceType": "Timing",
        "windowLower": "-P2D",
        "windowUpper": "P2D"
      },
      {
        "id": "timing_4",
        "name": "CRU Discharge",
        "type": {
          "id": "bc8ea061-6560-4a87-8573-67dcc5b482fb",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "PT6H",
        "valueLabel": "6 hours",
        "relativeToFrom": {
          "id": "aeb86e78-cb17-4834-8339-b8d7e7f0747b",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "c947154e-2ca3-4d45-8c4f-404e33a17b54",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_5",
        "name": "Study Drug Administration Timing",
        "type": {
          "id": "461f10bc-0e2f-44bb-b91a-eb613c8ec7bc",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "PT5M",
        "valueLabel": "5 minutes",
        "relativeToFrom": {
          "id": "b7402619-0845-4261-b7ed-07016c060f0c",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "8d7b49d1-0b17-4c83-a2aa-395f51807f90",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_6",
        "name": "Hypersensitivity Reaction Sampling",
        "type": {
          "id": "38a8d36f-3a1c-4e50-84c6-0a4245f7ab22",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P0D",
        "valueLabel": "Hypersensitivity Reaction Sampling",
        "relativeToFrom": {
          "id": "6a21806b-421f-4cb9-9e90-a346a0c42f19",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "a424ad8c-7a8d-400b-9152-6f2206675832",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_7",
        "name": "Additional Follow-up Sampling for TE ADA",
        "type": {
          "id": "97f06a80-d3c0-466d-bd67-766aa3abbeeb",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P84D",
        "valueLabel": "Day 84",
        "relativeToFrom": {
          "id": "cd754527-215f-41c9-8ff6-9055f715772b",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "f3e640cc-5875-41a9-a04c-f9262ec29911",
        "instanceType": "Timing",
        "windowLower": "-P7D",
        "windowUpper": "P7D"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Admission Rescheduling Condition",
        "instanceType": "Condition",
        "description": "Condition for rescheduling admission to the CRU on Day 1.",
        "text": "Admission can be rescheduled if PG level is not 90 to 250 mg/dL on Day 1."
      },
      {
        "id": "cond_2",
        "name": "Insulin Infusion Stop Condition",
        "instanceType": "Condition",
        "description": "Condition to stop the insulin infusion used to induce hypoglycemia.",
        "text": "Insulin infusion is stopped once bedside PG is <60 mg/dL."
      },
      {
        "id": "cond_3",
        "name": "Interim Safety Review Condition",
        "instanceType": "Condition",
        "description": "Condition for continuing the study after an initial cohort.",
        "text": "Safety data will be reviewed after the first 6 patients are administered LY900018 in Period 2. If no clinically significant safety findings for treatment or study procedure are noted, the remaining patients will be dosed."
      },
      {
        "id": "cond_4",
        "name": "Patient Replacement Criteria",
        "instanceType": "Condition",
        "description": "Criteria for replacing a discontinued patient.",
        "text": "If patients discontinue from the study before completion of both periods with evaluable primary outcome for any reason, the patient may be replaced. Replacement should not occur beyond 75 patients enrolled."
      },
      {
        "id": "cond_5",
        "name": "Non-inferiority Condition",
        "instanceType": "Condition",
        "description": "Statistical criteria for declaring non-inferiority of LY900018.",
        "text": "Non-inferiority of LY900018 will be declared if the upper limit of the 2-sided 95% CI constructed on the difference in percentage (IMG - LY900018) is less than the NIM of 10%."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Transition to Additional Follow-up",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_followup",
        "toElementId": "epoch_additional_followup",
        "text": "Patients with TE ADA at follow-up/ED will undergo additional follow-up."
      },
      {
        "id": "trans_2",
        "name": "Continuation of Inadvertently Enrolled Patient",
        "instanceType": "TransitionRule",
        "text": "If a patient who did not meet enrollment criteria was inadvertently enrolled, a discussion must occur between the Lilly CP/CRP and the investigator to determine if the patient may continue in the study with documented approval."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Patient completes both treatment periods and the final follow-up visit."
      },
      {
        "id": "exit_2",
        "name": "End of Additional Follow-up for TE ADA",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Additional follow-up for TE ADA ends when the titer returns to baseline or 1 year after the last dose of study treatment, whichever is first."
      },
      {
        "id": "exit_3",
        "name": "Discontinuation by Patient Decision",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The patient, or legal representative, requests to be withdrawn from the study."
      },
      {
        "id": "exit_4",
        "name": "Discontinuation by Investigator Decision",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The investigator decides that the patient should be discontinued from the study for any reason."
      },
      {
        "id": "exit_5",
        "name": "Discontinuation for Other Study Enrollment",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Patient enrolls in any other clinical study involving an investigational product or other medical research judged not to be compatible with this study."
      },
      {
        "id": "exit_6",
        "name": "Discontinuation for Medical/Safety/Regulatory Reasons",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Participation in the study needs to be stopped for medical, safety, regulatory, or other reasons."
      },
      {
        "id": "exit_7",
        "name": "Study Discontinuation for Safety",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Following the review of the safety data from the first 6 patients to complete Period 2 Day 1, the study will be stopped if deemed necessary for patient safety."
      },
      {
        "id": "exit_8",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A patient will be considered lost to follow-up if he or she repeatedly fails to return for scheduled visits and is unable to be contacted by the study site."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Interim Safety Review Decision",
        "timepointId": "after_6_patients_complete_period2",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point to continue dosing remaining patients based on safety review of the first 6 patients completing Period 2.",
        "conditionIds": [
          "cond_3"
        ]
      },
      {
        "id": "dec_2",
        "name": "Inadvertent Enrollment Decision",
        "timepointId": "as_identified",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point for continuing an inadvertently enrolled patient, which requires discussion and documented approval."
      }
    ],
    "summary": {
      "timingCount": 7,
      "conditionCount": 5,
      "transitionRuleCount": 2,
      "exitCount": 8
    }
  }
}